|
Volumn 70, Issue 13, 2002, Pages 1565-1575
|
Peroxisome proliferator-activated receptor γ reduces the growth rate of pancreatic cancer cells through the reduction of cyclin D1
|
Author keywords
Cyclin D1; Pancreatic cancer; Troglitazone
|
Indexed keywords
ALITRETINOIN;
CYCLIN D1;
LUCIFERASE;
MESSENGER RNA;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;
RETINOID X RECEPTOR;
THYMIDINE;
TROGLITAZONE;
ANIMAL CELL;
ARTICLE;
CANCER GROWTH;
CELL CYCLE G1 PHASE;
CELL GROWTH;
CELL PROLIFERATION;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG EFFECT;
ENZYME ACTIVITY;
GENETIC TRANSFECTION;
GROWTH RATE;
HUMAN;
HUMAN CELL;
NONHUMAN;
NORTHERN BLOTTING;
PANCREAS CANCER;
PROTEIN EXPRESSION;
RAT;
WESTERN BLOTTING;
ANIMALS;
ANTINEOPLASTIC AGENTS;
BLOTTING, NORTHERN;
BLOTTING, WESTERN;
CARCINOMA;
CELL DIVISION;
CHROMANS;
CYCLIN D1;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG SYNERGISM;
G1 PHASE;
HUMANS;
PANCREATIC NEOPLASMS;
RATS;
RECEPTORS, CYTOPLASMIC AND NUCLEAR;
RNA, MESSENGER;
THIAZOLES;
THIAZOLIDINEDIONES;
TRANSCRIPTION FACTORS;
TRANSFECTION;
TRETINOIN;
TUMOR CELLS, CULTURED;
|
EID: 0037083972
PISSN: 00243205
EISSN: None
Source Type: Journal
DOI: 10.1016/S0024-3205(01)01524-7 Document Type: Article |
Times cited : (54)
|
References (23)
|